Frontiers in Clinical Drug Research - Diabetes and Obesity: Volume 4 (eBook)
281 Seiten
Bentham Science Publishers (Verlag)
978-1-68108-445-9 (ISBN)
Frontiers in Clinical Drug Research - Diabetes and Obesity is an eBook series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of two metabolic diseases - diabetes and obesity. The scope of the eBook series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs affecting endocrine and metabolic processes linked with diabetes and obesity. Reviews in this series also include research on specific receptor targets and pre-clinical / clinical findings on novel pharmaceutical agents. Frontiers in Clinical Drug Research - Diabetes and Obesity is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of diabetes and obesity research.
The fourth volume of this series features 7 chapters:
-Pharmacologic Obesity Treatment
-Interplay Between Bile Acid and GLP-1 Receptor Agonist Signaling Informs the Design of Drugs to Combat Obesity and its Metabolic Complications
-Sodium-Glucose Co-Transporters Inhibitors for Type 2 Diabetes Mellitus
-The Effects of Traditional Chinese Medicine on Inflammatory Cytokines in Diabetic Nephropathy
-Through the Perspective of Histology - The Alzheimer's Disease Promotion by Obesity and Glucose Metabolism: Type 3 Diabetes
-Pharmacological Mechanism of PPARγ Ratio in Diabetes and Obesity
-Hydrogen Sulfide and Carbohydrate Metabolism
Frontiers in Clinical Drug Research - Diabetes and Obesity is an eBook series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of two metabolic diseases - diabetes and obesity. The scope of the eBook series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs affecting endocrine and metabolic processes linked with diabetes and obesity. Reviews in this series also include research on specific receptor targets and pre-clinical / clinical findings on novel pharmaceutical agents. Frontiers in Clinical Drug Research - Diabetes and Obesity is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of diabetes and obesity research.The fourth volume of this series features 7 chapters:-Pharmacologic Obesity Treatment-Interplay Between Bile Acid and GLP-1 Receptor Agonist Signaling Informs the Design of Drugs to Combat Obesity and its Metabolic Complications-Sodium-Glucose Co-Transporters Inhibitors for Type 2 Diabetes Mellitus-The Effects of Traditional Chinese Medicine on Inflammatory Cytokines in Diabetic Nephropathy-Through the Perspective of Histology - The Alzheimer's Disease Promotion by Obesity and Glucose Metabolism: Type 3 Diabetes-Pharmacological Mechanism of PPARy Ratio in Diabetes and Obesity-Hydrogen Sulfide and Carbohydrate Metabolism
| Erscheint lt. Verlag | 18.1.2019 |
|---|---|
| Reihe/Serie | Frontiers in Clinical Drug Research - Diabetes and Obesity | Frontiers in Clinical Drug Research - Diabetes and Obesity |
| Sprache | englisch |
| Themenwelt | Medizinische Fachgebiete ► Innere Medizin ► Endokrinologie |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Neurologie | |
| Medizin / Pharmazie ► Pflege | |
| Medizin / Pharmazie ► Pharmazie ► PTA / PKA | |
| Studium ► 1. Studienabschnitt (Vorklinik) ► Biochemie / Molekularbiologie | |
| Naturwissenschaften ► Biologie ► Biochemie | |
| Naturwissenschaften ► Chemie | |
| ISBN-10 | 1-68108-445-7 / 1681084457 |
| ISBN-13 | 978-1-68108-445-9 / 9781681084459 |
| Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
| Haben Sie eine Frage zum Produkt? |
Digital Rights Management: ohne DRM
Dieses eBook enthält kein DRM oder Kopierschutz. Eine Weitergabe an Dritte ist jedoch rechtlich nicht zulässig, weil Sie beim Kauf nur die Rechte an der persönlichen Nutzung erwerben.
Dateiformat: EPUB (Electronic Publication)
EPUB ist ein offener Standard für eBooks und eignet sich besonders zur Darstellung von Belletristik und Sachbüchern. Der Fließtext wird dynamisch an die Display- und Schriftgröße angepasst. Auch für mobile Lesegeräte ist EPUB daher gut geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen dafür die kostenlose Software Adobe Digital Editions.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen dafür eine kostenlose App.
Geräteliste und zusätzliche Hinweise
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich